Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1179

1.
2.

Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin.

Leung VW, Shalansky SJ, Lo MK, Jadusingh EA.

Ann Pharmacother. 2009 May;43(5):875-81. doi: 10.1345/aph.1L631. Epub 2009 Apr 28.

PMID:
19401475
3.

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

Arch Intern Med. 2000 Jun 12;160(11):1612-7.

PMID:
10847254
4.

Frequency of concurrent use of warfarin with potentially interacting drugs.

Wittkowsky AK, Boccuzzi SJ, Wogen J, Wygant G, Patel P, Hauch O.

Pharmacotherapy. 2004 Dec;24(12):1668-74.

PMID:
15585436
5.
6.

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE.

Ann Intern Med. 2004 Nov 16;141(10):745-52.

PMID:
15545674
7.

Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.

Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.

Ann Pharmacother. 2011 Jul;45(7-8):881-7. doi: 10.1345/aph.1P670. Epub 2011 Jul 12.

PMID:
21750309
8.

Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin.

Panneerselvam S, Baglin C, Lefort W, Baglin T.

Br J Haematol. 1998 Nov;103(2):422-4.

PMID:
9827914
9.

Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.

Subherwal S, Peterson ED, Chen AY, Roe MT, Washam JB, Gage BF, Bach RG, Bhatt DL, Wiviott SD, Lopes RD, Alexander KP, Wang TY.

Circulation. 2012 Mar 20;125(11):1414-23. doi: 10.1161/CIRCULATIONAHA.111.059188. Epub 2012 Feb 8.

10.

The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.

Parra D, Beckey NP, Stevens GR.

Pharmacotherapy. 2007 May;27(5):675-83.

PMID:
17461702
11.

International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle.

Kucher N, Connolly S, Beckman JA, Cheng LH, Tsilimingras KV, Fanikos J, Goldhaber SZ.

Arch Intern Med. 2004 Oct 25;164(19):2176-9.

PMID:
15505133
12.

Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.

Abdelhafiz AH, Wheeldon NM.

Am J Geriatr Pharmacother. 2008 Mar;6(1):1-11. doi: 10.1016/j.amjopharm.2008.03.005.

PMID:
18396243
13.
14.

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium..

Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.

PMID:
18657012
15.

Effect of age on international normalized ratio at the time of major bleeding in patients treated with warfarin.

Wittkowsky AK, Whitely KS, Devine EB, Nutescu E.

Pharmacotherapy. 2004 May;24(5):600-5.

PMID:
15162894
16.

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.

Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH.

Ann Intern Med. 1996 Jun 1;124(11):970-9.

PMID:
8624064
18.
19.

Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics.

White RH, McKittrick T, Takakuwa J, Callahan C, McDonell M, Fihn S.

Arch Intern Med. 1996 Jun 10;156(11):1197-201.

PMID:
8639014
20.

Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.

Perona S, Ford M, Rindone J.

J Pharm Pract. 2011 Oct;24(5):494-7. doi: 10.1177/0897190011418511.

PMID:
22156711

Supplemental Content

Support Center